Page 5 - Tom Graney News Today

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 12 convertible bonds in Oxurion resulting in a EUR 300,000 capital increase. This is part of Atlas

SOUTHEASTERN N.C. — Li’l Friday is a weekly roundup of events in art, music, theater, comedy, pop-up markets and more. It’s wise to check in ahead of attending…

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 14 convertible bonds in Oxurion resulting in a EUR 350,000 capital increase. This is part of Atlas

Regulated Information Leuven, BELGIUM, Boston, MA, US - May 3, 2023 - 9.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic

Regulated Information Leuven, BELGIUM, Boston, MA, US – May 3, 2023 – 9.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic... | June 17, 2023

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special

Investegate announcements from Oxurion NV, Oxurion Issues EUR 2.0 million in Bonds for Tranche 1 (B) of the Funding Program with Atlas Special Opportunities LLC

Leuven, BELGIUM, Boston, MA, US - April 27, 2023 - 7:00 pm CET - Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies,

Leuven, BELGIUM, Boston, MA, US – April 27, 2023 – 7:00 pm CET – Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with... | June 18, 2023

Investegate announcements from Oxurion NV, Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC